Lorcaserin Reviews

By Weight Loss Consultant • Related • Filed Under

Being used for weight loss, Lorcaserin hydrochloride or HCL is produced by a company named Arena.  They claim it to be the most advanced and promising option to hit the market, and apparently, they are currently in the process of undergoing serious clinical studies to publish its use and otherwise use it as a prescription for insomnia, thrombrosis, type 2 diabetes, and otherwise.

Apparently, they have a phase 3 program that currently consists of 3 trials.  They call it BLOOM or behavioral modification and Lorcaserin for overweight and obesity management.  They also have BLOOM-DM which is basically the same thing except with diabetes management.  And they have used over 7800 patients so far.

These results are actually presented initially speaking at the 69th scientific sessions of the American Diabetes Association in June of 2009.  They have shown positive results so far according to manufacturers, and apparently it is being submitted for New Drug Application submission.  Apparently, based on trial results thus far, it provides what they call a compelling profile.

So far, they have shown a variety of side effects in human clinical trials.  Less than 10% were reported to have dropped out.  But realistically speaking, when Acomplia actually came out with all the side effects of their trials and it came out that some suspect they hid results and harmful problems to sell their drug anyway, the public lost a lot of faith in the scientific community studying prescriptions.  The publications surrounding global warming certainly didn’t help.

Side effects with Lorcaserin that have been published generally include headaches, dizziness, and nausea.  Of course, these are very common to prescriptions.  But it is also known that prescriptions tend to be controlled due to far more serious side effects. It’s not just about the extra money that they end up making after they patent their product and spend actually quite a bit of money on trials that may not end up with FDA approval.  They have also shown that it may cause hyperactivity, oral dyskinesia, inappropriate proliferation of cardiac fibroblasts, hypolocomotion, hyperthermia, penile erection, depressive, and anxiogenic symptoms.

There are various future prospects with Lorcasin, and frankly, we like to see more than one study on each given benefit. Yes, they are trying to show multiple applications.  But in the scientific community, it is well noted that one must be able to actually duplicate any valid study under the same conditions with a different laboratory to avoid bias.

They have not actually show that as unfortunately many prescriptions for some reason don’t.  So we would suggest waiting around to see more studies on side effects, more studies on its application to weight loss, and more studies in general.  3 studies for a potentially dangerous prescription drug just seems like a small number to say the least.

Related information

Leave feedback on this product, program, diet or articles for future consumers!